AC-262,356

From Wikipedia, the free encyclopedia
Jump to: navigation, search
AC-262,356
AC-262,356.svg
Systematic (IUPAC) name
4-[(1R,3S,5S)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl]naphthalene-1-carbonitrile
Identifiers
CAS Number 870888-46-3
871032-12-1 (exo form)
ChemSpider 31129035
UNII U8VS41J5O6 YesY
ChEMBL CHEMBL3084525
Chemical data
Formula C18H18N2O
Molar mass 278.348 g/mol
  (verify)

AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen.[1]

References[edit]

  1. ^ Piu, F; Gardell, LR; Son, T; Schlienger, N; Lund, BW; Schiffer, HH; Vanover, KE; Davis, RE; Olsson, R; Bradley, SR (2008). "Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator". The Journal of Steroid Biochemistry and Molecular Biology. 109 (1–2): 129–37. doi:10.1016/j.jsbmb.2007.11.001. PMID 18164613.